First Trust Direct Indexing’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
First Trust Direct Indexing's BIIB Position: Q4 2024 in Review
First Trust Direct Indexing sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,213 shares — an estimated $235K sold.
First Trust Direct Indexing first reported a position in BIIB in Q4 2020 and held it in 16 quarters. The position peaked at $637K in Q2 2024. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- First Trust Direct Indexing reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- First Trust Direct Indexing sold 1,213 Biogen shares in Q4 2024, an estimated $235K.
- First Trust Direct Indexing first reported a position in Biogen in Q4 2020 and held it in 16 quarters.
- First Trust Direct Indexing's Biogen position peaked at $637K in Q2 2024.
- 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on First Trust Direct Indexing's 13F filing for Q4 2024.